Pitch for Investment

Experienced Investment Team

UKI2S > About > Team > Oliver Sexton
Oliver Sexton
“Turning world-leading research into profitable companies is no simple matter, but we are now at a point where many of those technologies are suitable for broad commercial application. UK Innovation & Science Seed Fund is providing not just capital, but the expertise and the networks to maximize the chances of success in existing markets and in the new markets that engineering biology enables.”

Oliver Sexton

Investment Director Engineering Biology

Oliver Sexton joined Midven in April 2014 to manage the UK Innovation & Science Seed Fund’s engineering biology investments.

Prior to joining Midven, Oliver managed commercialisation of bioengineering and medical technologies At Imperial Innovations and was on the board of oncology therapeutic Acublate Ltd. Earlier in his career he held commercial and partnering roles at Ark Therapeutics.

Oliver also managed a team of biotech buy-side analysts and worked at a pharma strategy consultancy.

Oliver has a BSc in Molecular Biology/Biotechnology and an MSc in Plant Science from Bristol University.

Follow on LinkedIn

Portfolio of Companies Managed

Zentraxa Logo

Zentraxa

Solasta Bio Logo

Solasta Bio

Pencil Biosciences Logo

Pencil Biosciences

NKIO Logo

NKIO

Ikarovec Logo

Ikarovec

HutanBio Logo

HutanBio

Bitrobius

Bitrobius

Antiverse Logo

Antiverse

UK Innovation & Science Seed Fund Team

View all Team Profiles

UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, t/a Midven, c/o WeWork, 55 Colmore Row, Birmingham, B3 2AA.

Stay updated